Seth Rudnick's most recent trade in G1 Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $22.3 . Disclosure was reported to the exchange on June 29, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| G1 Therapeutics Inc | Seth Rudnick | Director | Sale of securities on an exchange or to another person at price $ 22.35 per share. | 29 Jun 2021 | 10,000 | 4,389 (0%) | 0% | 22.3 | 223,477 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 7,969 | 0 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. | 29 Jun 2021 | 7,969 | 12,358 (0%) | 0% | 0.4 | 3,108 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 29 Jun 2021 | 2,031 | 14,389 (0%) | 0% | 0.3 | 609 | Common Stock |
| G1 Therapeutics Inc | Seth Rudnick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 2,031 | 11,859 | - | - | Stock Option (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,620 | 19,620 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 4,389 | 4,389 (0%) | 0% | 0 | Common Stock |